Blue Heron Calls Codon IP Lawsuit 'Baseless' and 'Without Merit' | GenomeWeb
NEW YORK (GenomeWeb News) –  Blue Heron Biotechnologies yesterday said that a patent-infringement lawsuit filed against it by Codon Devices and two major universities is “baseless” and “without merit.”
 
As GenomeWeb News reported yesterday, Codon, Duke University, and the Massachusetts Institute of Technology allege that Blue Heron is infringing five US Patents relating to synthetic nucleic acid technologies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.